ICE Stock Overview
Medinice S.A. focuses on creating, developing, and commercializing medical technologies for cardiology and cardio surgery.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Medinice S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł8.10 |
| 52 Week High | zł18.05 |
| 52 Week Low | zł7.82 |
| Beta | 0.96 |
| 1 Month Change | -15.80% |
| 3 Month Change | -17.68% |
| 1 Year Change | -47.06% |
| 3 Year Change | -75.08% |
| 5 Year Change | 28.57% |
| Change since IPO | -25.00% |
Recent News & Updates
Shareholder Returns
| ICE | PL Medical Equipment | PL Market | |
|---|---|---|---|
| 7D | -12.4% | -1.2% | 3.5% |
| 1Y | -47.1% | -6.5% | 27.4% |
Return vs Industry: ICE underperformed the Polish Medical Equipment industry which returned -6.5% over the past year.
Return vs Market: ICE underperformed the Polish Market which returned 27.4% over the past year.
Price Volatility
| ICE volatility | |
|---|---|
| ICE Average Weekly Movement | 7.1% |
| Medical Equipment Industry Average Movement | 4.7% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in PL Market | 9.6% |
| 10% least volatile stocks in PL Market | 3.1% |
Stable Share Price: ICE's share price has been volatile over the past 3 months.
Volatility Over Time: ICE's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of Polish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 16 | Sanjeev Choudhary | www.medinice.pl |
Medinice S.A. focuses on creating, developing, and commercializing medical technologies for cardiology and cardio surgery. The company provides advisory services in the field of commercialization of research and development products; and undertakes preclinical tests, clinical trials, and obtaining a certificate for sale of medical technology. Medinice S.A. was incorporated in 2012 and is headquartered in Warsaw, Poland.
Medinice S.A. Fundamentals Summary
| ICE fundamental statistics | |
|---|---|
| Market cap | zł52.34m |
| Earnings (TTM) | -zł5.07m |
| Revenue (TTM) | zł225.00k |
232.6x
P/S Ratio-10.3x
P/E RatioIs ICE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ICE income statement (TTM) | |
|---|---|
| Revenue | zł225.00k |
| Cost of Revenue | zł150.00k |
| Gross Profit | zł75.00k |
| Other Expenses | zł5.15m |
| Earnings | -zł5.07m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 28, 2024
| Earnings per share (EPS) | -0.78 |
| Gross Margin | 33.33% |
| Net Profit Margin | -2,254.22% |
| Debt/Equity Ratio | 0% |
How did ICE perform over the long term?
See historical performance and comparison